Refine Results
  1. "Robert Motzer"
Formats
  1. Journal Article (401)
  2. Meeting Abstract (273)
  3. Book Section (18)
  4. Conference Paper (3)
  5. Book Whole (2)
Groups
  1. Genitourinary Oncology Service (697)
  2. Solid Tumor Oncology Division (697)
  3. Genitourinary Disease Management Team (694)
  4. Surgery (181)
  5. Survivorship Research (131)
  6. Population Sciences Research Program (94)

More Groups

People
  1. Robert Motzer (697)
  2. George Bosl (109)
  3. Joel Sheinfeld (92)
  4. Darren Feldman (84)
  5. Dean Bajorin (81)
  6. Paul Russo (67)

More People

Years
  1. 2019 (2)
  2. 2018 (42)
  3. 2017 (38)
  4. 2016 (58)
  5. 2015 (58)
  6. 2014 (54)

More Years

Publications
  1. Journal of Clinical Oncology (205)
  2. Annals of Oncology (41)
  3. BJU International (37)
  4. European Journal of Cancer (30)
  5. Journal of Urology (23)
  6. Cancer (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (206)
  2. Elsevier Science, Inc. (75)
  3. Elsevier Inc. (68)
  4. Wiley Blackwell (60)
  5. Oxford University Press (47)
  6. Nature Publishing Group (33)

More Publishers

Results (697)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations
    Journal Article

    Manley, B. J.; Reznik, E.; Ghanaat, M.; Kashan, M.; Becerra, M. F.; Casuscelli, J.; Tennenbaum, D.; Redzematovic, A.; Carlo, M. I.; Sato, Y.; more...
    Urologic Oncology: Seminars and Original Investigations (2019)

    Fulltext@MSK | Save
  • Systemic treatment of metastatic clear cell renal cell carcinoma in 2018: Current paradigms, use of immunotherapy, and future directions
    Journal Article

    Lalani, A. K. A.; McGregor, B. A.; Albiges, L.; Choueiri, T. K.; Motzer, R.; Powles, T.; Wood, C.; Bex, A.
    European Urology (2019)

    Fulltext@MSK | Save
  • IMmotion151: A randomized phase III study of atezolizumab plus bevacizumab vs sunitinib in untreated metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Motzer, R. J.; Powles, T.; Atkins, M. B.; Escudier, B.; McDermott, D. F.; Suarez, C.; Bracarda, S.; Stadler, W. M.; Donskov, F.; Lee, J. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 3 trial to compare efficacy and safety of lenvatinib in combination with everolimus or pembrolizumab versus sunitinib alone in first-line treatment of patients with metastatic renal cell carcinoma
    Meeting Abstract

    Motzer, R. J.; Grunwald, V.; Hutson, T. E.; Porta, C.; Powles, T.; Eto, M.; Dutcus, C. E.; Baig, M. A.; Dutta, L.; Li, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Exploratory pharmacogenomic analysis
    Meeting Abstract

    George, D. J.; Martini, J. F.; Staehler, M. D.; Chang, Y. H.; Breza, J.; Patard, J. J.; Motzer, R. J.; Magheli, A.; Carteni, G.; Donskov, F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomically annotated risk model for advanced renal-cell carcinoma: A retrospective cohort study
    Journal Article

    Voss, M. H.; Reising, A.; Cheng, Y.; Patel, P.; Marker, M.; Kuo, F.; Chan, T. A.; Choueiri, T. K.; Hsieh, J. J.; Hakimi, A. A.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • Important group differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms in patients with metastatic renal cell carcinoma
    Journal Article

    Cella, D.; Motzer, R. J.; Rini, B. I.; Cappelleri, J. C.; Ramaswamy, K.; Hariharan, S.; Arondekar, B.; Bushmakin, A. G.
    Value in Health (2018)

    Fulltext@MSK | Save
  • Long-term response to sunitinib treatment in metastatic renal cell carcinoma: A pooled analysis of clinical trials
    Journal Article

    Tannir, N. M.; Figlin, R. A.; Gore, M. E.; Michaelson, M. D.; Motzer, R. J.; Porta, C.; Rini, B. I.; Hoang, C.; Lin, X.; Escudier, B.
    Clinical Genitourinary Cancer (2018)

    Fulltext@MSK | Save
  • Combination VEGFR/immune checkpoint inhibitor therapy: A promising new treatment for renal cell carcinoma
    Journal Article

    Lee, C. H.; Motzer, R.
    British Journal of Cancer (2018)

    Fulltext@MSK | Save